CYDY insider trading
OTC Markets OTCQB HealthcareCytoDyn Inc.: insider trade history from SEC Form 4 filings.
About CytoDyn Inc.
CytoDyn Inc., a clinical-stage biotechnology company, develops treatments for multiple therapeutic indications. It is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19. The company's leronlimab is currently under phase 2 development for the treatment of micro-satellite stable colorectal cancer, and solid tumors in oncology, such as metastatic triple-negative breast cancer. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.
Company website: www.cytodyn.com
CYDY insider activity at a glance
FilingIQ tracks 215 insider transactions for CYDY in filings since Jun 26, 2015. The most recent transaction is dated Feb 13, 2023.
Across the full history, 10 open-market purchases
and 11 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on CYDY insider trades is 57.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest CYDY Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for CYDY?
- FilingIQ tracks 215 Form 4 insider transactions for CYDY (CytoDyn Inc.), covering filings from Jun 26, 2015 onwards. 0 of those are dated within the last 90 days.
- Are CYDY insiders net buyers or net sellers?
- Across the full Form 4 history for CYDY, 10 transactions (5%) were open-market purchases and 11 (5%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does CYDY insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is CYDY in?
- CytoDyn Inc. (CYDY) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $339.83M.
Methodology & sources
Every CYDY insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.